Profile: Jason Dean
The entity listed in the case data as "Jason Dean" is a natural person, not a corporation. He is the founder and CEO of Eget Liber, Inc., an environmental technology startup based at 235 Harrison Street, Syracuse, New York, founded in 2019. Eget Liber is privately held and was a 2020 finalist in the GENIUS NY accelerator, from which it received a reported $500,000 investment. Tracxn lists the company at roughly four employees as of mid-2024; no revenue figure is published. Public sources do not disclose Dean's personal ownership stakes or compensation.
Operations. Eget Liber develops chemical-free mitigation technology for harmful algal blooms (cyanobacteria) in freshwater lakes: an autonomous, semi-submersible remotely operated vehicle that irradiates algae with ultraviolet light, paired with aerial or surface detection. Its customers are described in press coverage as lake associations, municipalities, and lakefront property owners. Dean's background before founding the company was as a middle school science teacher in Union Springs, New York.
Litigation posture. The single tracked matter, Eget Liber, Inc. et al. v. Clear Water Systems Limited et al., filed 2025-12-01 in New York Supreme Court, Onondaga County, is a Commercial and Trade – Contract action, not a patent suit. Dean appears as one of four plaintiffs alongside Eget Liber, Inc., RanMarine Technologies BV, and RanMarine founder Richard Hardiman. The defendants are Belfast-based Clear Water Systems Limited and its managing director, Richard James Boyd. Dean's tracked case count is 1 as plaintiff and 0 as defendant; there is no evidence of patent-assertion or NPE activity. The venue is Onondaga County (Syracuse) — the plaintiffs' home forum, not a patent venue.
Context. The case follows a publicly announced three-way collaboration: RanMarine (Rotterdam) supplies autonomous surface vessels, Eget Liber the algae-treatment payload, and Clear Water Systems participated in a DAERA-funded pilot on Lough Neagh, Northern Ireland. Docket filings reference a "Eget Liber Reactor," DAERA Phase 1/Phase 2 agreements, and 2024–2025 correspondence between Dean and Boyd. The merits are unresolved.